Graphene-Based Nanoparticles as Potential Treatment Options for Parkinson's Disease: A Molecular Dynamics Study.

Ehsan AlimohammadiMohammad KhedriAhmad Miri JahromiReza MalekiMilad Rezaian

Published in: International journal of nanomedicine (2020)

Ultimately, it was concluded that N-Graphene could be the most effective monolayer to disrupt amyloid fibrillation, and consequently, prevent the progression of Parkinson's disease.

Keyphrases

molecular dynamics
density functional theory
room temperature
carbon nanotubes